Reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer.
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AF Detoxifying agents for antineoplastic treatment
V03AF05 Amifostine
D00226 Amifostine (USP) <US>
USP drug classification [BR:br08302]
Antineoplastics
Antineoplastic Adjuncts/Mitigators
Amifostine
D00226 Amifostine (USP)